Gabrielle Munzer has been promoted to Spouse at deep tech undertaking funds business Main Sequence. Gabrielle will deal with the firm’s renewed emphasis on bringing biotechnology (biotech) study to scale in her new role.
Gabrielle has been an integral aspect of the Fund’s “Feed 10 Billion Persons” and “Decarbonise the Planet”obstacle during her 3 decades at Main Sequence, aiding in the generation of new firms these kinds of as animal-cost-free dairy enterprise Eden Brew and infinite plastic recycling enterprise Samsara Eco.
This 12 months, she teamed with UNSW to start Australia’s 1st biotech accelerator programme, SynBio 10x, to support companies in accelerating their biotech or synthetic biology (SynBio) products improvement and commercialisation.
As Australia embraces world-wide bio-revolution, Gabrielle Munzer, Lover at Principal Sequence, instructed Dynamic Company, “Australia has a great prospect to come to be a leader in the fields of synthetic biology (synbio) and biotechnology.
“With higher emphasis currently being place on our environmental output and the foreseeable future of our earth, we are looking at Australian researchers delve deeper into reimagining the long term of food, agriculture, plastics and far more.
“But this is just the commencing of exactly where we’re headed. Solving the world’s biggest challenges demands considerably collaboration, and that’s where by systems this kind of as our SynBio 10x accelerator come to be so impressive.
“As our investigation base carries on to mature, the plan serves as a way for us to support the burgeoning synthetic biology field in Australia, serving to to quickly-monitor startups in the discipline, giving mentorship, infrastructure and cash.”
A $27 billion option
Primary Sequence was released in Australia in 2017 to tackle the CSIRO Innovation Fund, which was founded by the Australian Federal government and the nationwide science agency to reinvest its historic contributions into foreseeable future triumphs. Main Sequence’s Fund I and Fund II have invested in 42 companies that are reworking healthcare delivery, meals creation, and place connectivity, amid other things.
Quasar Satellite Technologies, Endua, Eden Brew, and Samsara Eco ended up all born from Main Sequence’s Fund II, which saw the fruition of the firm’s innovative Venture Science model’s added benefits. The approach consists of deciding on a significant international problem and putting alongside one another a analysis team to handle it. The corporation will continue to aim on biologically-centered remedies to handle the world’s most urgent difficulties through Venture Science in its approaching Fund III.
With assist from the small business local community, CSIRO predicts that SynBio-enabled solutions could have a profound effects on the entire world and place Australia for a $27 billion option that could produce 44 thousand new employment by 2040.
Key Sequence Founding Partner Phil Morle claimed, “Biology and nature’s smallest aspects have shaped the foundation of a lot of foremost innovations, for instance, the insulin that is used for treating diabetes. Currently, we’re only scratching the surface of the opportunities biotech and SynBio supply. Gabrielle is an significant voice inside of Key Sequence, pushing the boundaries and unearthing the up coming generation of breakthrough innovations.
“She provides a unique standpoint dependent on many years of assisting to inspire leaders and make corporations that obstacle the way we assume about alleviating the environment from human destruction.”
Researchers could defeat some of Australia’s most significant challenges with the assist of synthetic biology-enabled answers, which have programs in fields which include wellbeing, agriculture, biosecurity, and the surroundings. In accordance to CSIRO, by 2040, artificial biology could deliver up to $27 billion in once-a-year revenue and 44,000 new work for Australia underneath a significant progress, superior market place share scenario.
This Countrywide Artificial Biology Roadmap report, posted in August 2021, information the likely positive aspects of synthetic biology for Australia and offers solutions for how to speed up the improvement, scalability, and professional accomplishment of its makes use of.
Additional on Main Sequence.
More right here.